The Effects of Caffeine on Blood Platelets and the Cardiovascular System through Adenosine Receptors.
Kinga MarcinekBogusława LuzakMarcin RozalskiPublished in: International journal of molecular sciences (2024)
Caffeine is the most popular and widely consumed behaviourally active substance in the world. This review describes the influence of caffeine on the cardiovascular system, with a special focus on blood platelets. For many years, caffeine was thought to have a negative effect on the cardiovascular system mainly due to increasing blood pressure. However, more recent data suggest that habitual caffeine consumption may reduce the risk of cardiovascular disease and hypertension. This could be a significant finding as cardiovascular disease is the leading cause of death worldwide. Caffeine is known to inhibit A 1 adenosine receptors, through which it is believed to modulate inter alia coronary blood flow, total peripheral resistance, diuresis, and heart rate. It has been shown that coffee possesses antiplatelet activity, but depending on the dose and the term of its use, caffeine may stimulate or inhibit platelet reactivity. Also, chronic exposure to caffeine may sensitize or upregulate the adenosine receptors in platelets causing increased cAMP accumulation and anti-aggregatory effects and decrease calcium levels elicited by AR agonists. The search for new, selective, and safe AR agonists is one of the new strategies for improving antiplatelet therapy involving targeting multiple pathways of platelet activation. Therefore, this review examines the AR-dependent impact of caffeine on blood platelets in the presence of adenosine receptor agonists.
Keyphrases
- blood pressure
- heart rate
- cardiovascular disease
- blood flow
- antiplatelet therapy
- heart rate variability
- type diabetes
- acute coronary syndrome
- protein kinase
- percutaneous coronary intervention
- coronary artery disease
- hypertensive patients
- artificial intelligence
- preterm infants
- deep learning
- machine learning
- electronic health record
- cancer therapy
- skeletal muscle
- atrial fibrillation
- drug delivery
- big data
- ejection fraction
- blood glucose